Angelo Lombardo

6.4k total citations · 3 hit papers
46 papers, 4.0k citations indexed

About

Angelo Lombardo is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Angelo Lombardo has authored 46 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 25 papers in Genetics and 12 papers in Oncology. Recurrent topics in Angelo Lombardo's work include CRISPR and Genetic Engineering (25 papers), Virus-based gene therapy research (22 papers) and RNA Interference and Gene Delivery (18 papers). Angelo Lombardo is often cited by papers focused on CRISPR and Genetic Engineering (25 papers), Virus-based gene therapy research (22 papers) and RNA Interference and Gene Delivery (18 papers). Angelo Lombardo collaborates with scholars based in Italy, United States and Spain. Angelo Lombardo's co-authors include Luigi Naldini, Michael C. Holmes, Pietro Genovese, Philip D. Gregory, Antonia Follenzi, Angelo Amabile, Andrea Annoni, Mauro Biffi, Christian Beauséjour and Dale Ando and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Angelo Lombardo

43 papers receiving 3.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery

2007 647 citations Angelo Lombardo, Pietro Genovese et al. Nature Biotechnology profile →
Targeted genome editing in human repopulating haematopoietic stem cells

2014 434 citations Pietro Genovese, Giulia Schiroli et al. Nature profile →
Durable and efficient gene silencing in vivo by hit-and-run epigenome editing

2024 91 citations Simone Merlin, Angelo Lombardo et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Angelo Lombardo Italy	26	3.2k	1.8k	665	320	278	46	4.0k
Eugenio Montini Italy	38	3.9k 1.2×	2.9k 1.6×	1.2k 1.8×	528 1.6×	317 1.1×	74	5.2k
Daniel P. Dever United States	17	2.4k 0.7×	947 0.5×	424 0.6×	176 0.6×	202 0.7×	28	2.9k
Shondra M. Pruett‐Miller United States	32	3.0k 0.9×	717 0.4×	342 0.5×	590 1.8×	275 1.0×	97	3.8k
Masashi Urabe Japan	29	2.2k 0.7×	1.7k 0.9×	547 0.8×	267 0.8×	308 1.1×	98	3.3k
Richard Eckner United States	26	4.8k 1.5×	1.7k 0.9×	1.7k 2.6×	880 2.8×	285 1.0×	30	6.3k
Andrew Wilber United States	28	1.7k 0.5×	556 0.3×	895 1.3×	387 1.2×	170 0.6×	62	2.8k
Adrian P. Bracken Ireland	33	7.4k 2.3×	1.0k 0.6×	1.1k 1.7×	553 1.7×	187 0.7×	47	8.5k
Ya‐Wen Chiang United States	26	2.6k 0.8×	2.6k 1.5×	1.3k 1.9×	544 1.7×	502 1.8×	42	4.5k
Peter C. Scacheri United States	41	4.8k 1.5×	1.0k 0.6×	769 1.2×	424 1.3×	715 2.6×	80	6.5k
Daniele Guardavaccaro United States	30	5.2k 1.6×	603 0.3×	1.9k 2.9×	443 1.4×	394 1.4×	55	6.2k

Countries citing papers authored by Angelo Lombardo

Since Specialization

Citations

This map shows the geographic impact of Angelo Lombardo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angelo Lombardo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angelo Lombardo more than expected).

Fields of papers citing papers by Angelo Lombardo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angelo Lombardo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angelo Lombardo. The network helps show where Angelo Lombardo may publish in the future.

Co-authorship network of co-authors of Angelo Lombardo

This figure shows the co-authorship network connecting the top 25 collaborators of Angelo Lombardo. A scholar is included among the top collaborators of Angelo Lombardo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angelo Lombardo. Angelo Lombardo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Höhn, Miriam, et al.. (2024). Lipo-Xenopeptide Polyplexes for CRISPR/Cas9 based Gene editing at ultra-low dose. Journal of Controlled Release. 370. 239–255. 12 indexed citations

Baccega, Tania, S. Torchio, Silvia Pellegrini, et al.. (2022). Engineering of immune checkpoints B7-H3 and CD155 enhances immune compatibility of MHC-I−/− iPSCs for β cell replacement. Cell Reports. 40(13). 111423–111423. 19 indexed citations

Soldi, Monica, Lucia Sergi Sergi, Giulia Unali, et al.. (2020). Laboratory-Scale Lentiviral Vector Production and Purification for Enhanced Ex Vivo and In Vivo Genetic Engineering. Molecular Therapy — Methods & Clinical Development. 19. 411–425. 25 indexed citations

Rosato, Anna Scotto, Sandro Montefusco, Chiara Soldati, et al.. (2019). TRPML1 links lysosomal calcium to autophagosome biogenesis through the activation of the CaMKKβ/VPS34 pathway. Nature Communications. 10(1). 5630–5630. 139 indexed citations

Olgasi, Cristina, Maria Talmon, Simone Merlin, et al.. (2018). Patient-Specific iPSC-Derived Endothelial Cells Provide Long-Term Phenotypic Correction of Hemophilia A. Stem Cell Reports. 11(6). 1391–1406. 47 indexed citations

Díez, Begoña, Pietro Genovese, Francisco J Roman‐Rodriguez, et al.. (2017). Therapeutic gene editing in CD 34 ⁺ hematopoietic progenitors from Fanconi anemia patients. EMBO Molecular Medicine. 9(11). 1574–1588. 44 indexed citations

Schiroli, Giulia, Samuele Ferrari, Anthony Conway, et al.. (2017). Preclinical modeling highlights the therapeutic potential of hematopoietic stem cell gene editing for correction of SCID-X1. Science Translational Medicine. 9(411). 159 indexed citations

Cantore, Alessio, Andrea Annoni, Tongyao Liu, et al.. (2017). Liver-Directed Gene Therapy for Hemophilia B with Immune Stealth Lentiviral Vectors. Blood. 130. 605–605. 4 indexed citations

Annoni, Andrea, Mauro Biffi, Fabio Russo, et al.. (2017). Genome editing for scalable production of alloantigen‐free lentiviral vectors for in vivo gene therapy. EMBO Molecular Medicine. 9(11). 1558–1573. 44 indexed citations

10.

Andolfi, Grazia, Fabio Russo, Antonello E. Spinelli, et al.. (2017). IL-10-Engineered Human CD4+ Tr1 Cells Eliminate Myeloid Leukemia in an HLA Class I-Dependent Mechanism. Molecular Therapy. 25(10). 2254–2269. 41 indexed citations

11.

Amabile, Angelo, Alessandro Migliara, Paola Capasso, et al.. (2016). Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing. Cell. 167(1). 219–232.e14. 351 indexed citations

12.

Néri, Tui, Sharon Muggeo, Marianna Paulis, et al.. (2015). Targeted Gene Correction in Osteopetrotic-Induced Pluripotent Stem Cells for the Generation of Functional Osteoclasts. Stem Cell Reports. 5(4). 558–568. 18 indexed citations

13.

Friedli, Marc, Priscilla Turelli, Adamandia Kapopoulou, et al.. (2014). Loss of transcriptional control over endogenous retroelements during reprogramming to pluripotency. Genome Research. 24(8). 1251–1259. 77 indexed citations

14.

Lombardo, Angelo & Luigi Naldini. (2014). Genome Editing: A Tool For Research and Therapy: Targeted genome editing hits the clinic. Nature Medicine. 20(10). 1101–1103. 15 indexed citations

15.

Genovese, Pietro, Giulia Schiroli, Giulia Escobar, et al.. (2014). Targeted genome editing in human repopulating haematopoietic stem cells. Nature. 510(7504). 235–240. 434 indexed citations breakdown →

16.

Friedli, Marc, Giulia Fragola, Angelo Lombardo, et al.. (2011). Genomic instability in induced stem cells. Cell Death and Differentiation. 18(5). 745–753. 114 indexed citations

17.

Brown, Brian D., Alessio Cantore, Andrea Annoni, et al.. (2007). A microRNA-regulated lentiviral vector mediates stable correction of hemophilia B mice. Blood. 110(13). 4144–4152. 194 indexed citations

18.

Lombardo, Angelo, Pietro Genovese, Christian Beauséjour, et al.. (2007). Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery. Nature Biotechnology. 25(11). 1298–1306. 647 indexed citations breakdown →

19.

Follenzi, Antonia, Manuela Battaglia, Angelo Lombardo, et al.. (2004). Targeting lentiviral vector expression to hepatocytes limits transgene-specific immune response and establishes long-term expression of human antihemophilic factor IX in mice. Blood. 103(10). 3700–3709. 167 indexed citations

20.

Natale, Paola Di, Carmela Di Domenico, G. Villani, et al.. (2002). In vitro gene therapy of mucopolysaccharidosis type I by lentiviral vectors. European Journal of Biochemistry. 269(11). 2764–2771. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact